Publication:
A mucormycosis case treated with a combination of caspofungin and amphotericin B

dc.contributor.authorErişen, Levent M.
dc.contributor.buuauthorKazak, Esra
dc.contributor.buuauthorAslan, Emel
dc.contributor.buuauthorAkalın, Halis
dc.contributor.buuauthorSaraydaroǧlu, Özlem
dc.contributor.buuauthorHakyemez, Bahattin
dc.contributor.buuauthorYazıcı, Bülent
dc.contributor.buuauthorGürcüoǧlu, Emel
dc.contributor.buuauthorYılmaz, Emel
dc.contributor.buuauthorEner, Beyza
dc.contributor.buuauthorHelvacı, Safiye
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentMikrobiyoloji Ana Bilim Dalı
dc.contributor.departmentGöz Hastalıkları Ana Bilim Dalı
dc.contributor.departmentRadyoloji Ana Bilim Dalı
dc.contributor.departmentEnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalı
dc.contributor.departmentPatoloji Ana Bilim Dalı
dc.contributor.orcid0000-0002-4803-8206
dc.contributor.orcid0000-0002-3425-0740
dc.contributor.researcheridAAG-8523-2021
dc.contributor.researcheridAAI-2318-2021
dc.contributor.researcheridAAA-5384-2020
dc.contributor.researcheridAAG-8459-2021
dc.contributor.scopusid24921238200
dc.contributor.scopusid55062356800
dc.contributor.scopusid57207553671
dc.contributor.scopusid15074395500
dc.contributor.scopusid6602527239
dc.contributor.scopusid7005398015
dc.contributor.scopusid24502872100
dc.contributor.scopusid22037135100
dc.contributor.scopusid15053025300
dc.contributor.scopusid6602103491
dc.date.accessioned2022-10-14T12:49:37Z
dc.date.available2022-10-14T12:49:37Z
dc.date.issued2013-09
dc.description.abstractMucormycosis is a rare, invasive and fatal disease that occurs mainly in diabetes mellitus patients with uncontrolled blood glucose levels or in immunocompromised patients. The mortality rate of this disease is as high as 25 to 80%, despite aggressive surgical treatment and antifungal therapy. This high mortality requires alternative treatment approaches. The accepted treatment modality of invasive mucormycosis are amphotericin B lipid formulations. Although echinocandins generally show no activity against Mucorales, it was shown that Rhizopus oryzae expressed the target enzyme for echinocandins, 1,3-beta-glucan synthase. Additionally, there are some experimental studies in a diabetic mouse model and case reports regarding the effects of caspofungin. In this report, we present a rhinocerebral mucormycosis case treated with liposomal amphotericin B and caspofungin. There was regression of the patient's clinical and radiological condition with the addition of caspofungin, but she died due to discontinuation of her treatment and reasons other than mucormycosis.
dc.identifier.citationKazak, E. vd. (2013). "A mucormycosis case treated with a combination of caspofungin and amphotericin B". Journal de Mycologie Medicale, 23(3), 179-184.
dc.identifier.endpage184
dc.identifier.issn1156-5233
dc.identifier.issn1773-0449
dc.identifier.issue3
dc.identifier.pubmed23856448
dc.identifier.scopus2-s2.0-84883220784
dc.identifier.startpage179
dc.identifier.urihttps://doi.org/10.1016/j.mycmed.2013.06.003
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S1156523313000590
dc.identifier.urihttp://hdl.handle.net/11452/29114
dc.identifier.volume23
dc.identifier.wos000324962300006
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherMasson Editeur
dc.relation.collaborationSanayi
dc.relation.journalJournal de Mycologie Medicale
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectMycology
dc.subjectMucormycosis
dc.subjectCaspofungin
dc.subjectAmphotericin B
dc.subjectZygomycosis
dc.subjectEpidemology
dc.subjectTherapy
dc.subjectAcetate
dc.subjectMucorales
dc.subjectRhizopus oryzae
dc.subjectAmphotericin B
dc.subjectAmphotéricine B
dc.subjectCaspofungin
dc.subjectCaspofungine
dc.subjectMucormycose
dc.subjectMucormycosis
dc.subject.emtreeAmphotericin B lipid complex
dc.subject.emtreeCaspofungin
dc.subject.emtreeCiprofloxacin
dc.subject.emtreeInsulin
dc.subject.emtreeMeropenem
dc.subject.emtreeVancomycin
dc.subject.emtreeAbdominal pain
dc.subject.emtreeAdult
dc.subject.emtreeArticle
dc.subject.emtreeCase report
dc.subject.emtreeCavernous sinus
dc.subject.emtreeClinical feature
dc.subject.emtreeConfusion
dc.subject.emtreeCreatinine blood level
dc.subject.emtreeDeath
dc.subject.emtreeDecompression surgery
dc.subject.emtreeDiabetes mellitus
dc.subject.emtreeDialysis
dc.subject.emtreeDiffusion weighted imaging
dc.subject.emtreeDisease exacerbation
dc.subject.emtreeDrug efficacy
dc.subject.emtreeDrug safety
dc.subject.emtreeDrug withdrawal
dc.subject.emtreeElectroencephalography
dc.subject.emtreeEndoscopic sinus surgery
dc.subject.emtreeEndoscopic surgery
dc.subject.emtreeEye swelling
dc.subject.emtreeFacial nerve paralysis
dc.subject.emtreeFemale
dc.subject.emtreeFungal cell
dc.subject.emtreeHepatosplenomegaly
dc.subject.emtreeHistopathology
dc.subject.emtreeHospital discharge
dc.subject.emtreeHospitalization
dc.subject.emtreeHuman
dc.subject.emtreeHuman tissue
dc.subject.emtreeHyperemia
dc.subject.emtreeHypoglycemia
dc.subject.emtreeImage analysis
dc.subject.emtreeIntubation
dc.subject.emtreeLoading drug dose
dc.subject.emtreeMagnetic resonance angiography
dc.subject.emtreeMaxilla resection
dc.subject.emtreeMetabolic encephalopathy
dc.subject.emtreeMucormycosis
dc.subject.emtreeNasolabial fold
dc.subject.emtreeNuclear magnetic resonance
dc.subject.emtreeOrbit cellulitis
dc.subject.emtreePatient attitude
dc.subject.emtreePhysical examination
dc.subject.emtreePostoperative period
dc.subject.emtreeRespiratory arrest
dc.subject.emtreeRhinocerebral mucormycosis
dc.subject.emtreeSepsis
dc.subject.emtreeTreatment response
dc.subject.emtreeUrea blood level
dc.subject.emtreeUrinary tract infection
dc.subject.meshAdult
dc.subject.meshAmphotericin B
dc.subject.meshAntifungal agents
dc.subject.meshDiabetes complications
dc.subject.meshDrug therapy, combination
dc.subject.meshEchinocandins
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshImmunocompromised host
dc.subject.meshMucormycosis
dc.subject.scopusCase Report; Posaconazole; Mucorales
dc.subject.wosMycology
dc.titleA mucormycosis case treated with a combination of caspofungin and amphotericin B
dc.typeArticle
dc.wos.quartileQ4
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Patoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Radyoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Mikrobiyoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Göz Hastalıkları Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: